APT-1011: Clinical Trials

1 trial of APT-1011, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow APT-1011: new trials by email Literature Review of APT-1011 trials Research Report on APT-1011

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
APT-1011, Placebo - Eosinophilic Esophagitis
Phase 2CompletedAdare Pharmaceuticals, Inc.1062017-06-222023-04-26

Conditions studied

Deglutition Disorders (1)  ·  Digestive System Diseases (1)  ·  Eosinophilic Esophagitis (1)  ·  Esophageal Diseases (1)  ·  Esophagitis (1)  ·  Gastrointestinal Diseases (1)

Sponsors

Adare Pharmaceuticals, Inc. (1)

Countries

Belgium (1)  ·  Canada (1)  ·  Germany (1)  ·  Spain (1)  ·  Switzerland (1)  ·  United States (1)

Top investigators

Peter C Richardson (1)

Results publications

PMID 35181572

NIH funding

2016 (1)